BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9469325)

  • 1. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
    Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
    J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
    Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
    Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
    Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
    Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer.
    Lanza G; Matteuzzi M; Gafá R; Orvieto E; Maestri I; Santini A; del Senno L
    Int J Cancer; 1998 Aug; 79(4):390-5. PubMed ID: 9699532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
    Watanabe T; Wu TT; Catalano PJ; Ueki T; Satriano R; Haller DG; Benson AB; Hamilton SR
    N Engl J Med; 2001 Apr; 344(16):1196-206. PubMed ID: 11309634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss of chromosome 18q and prognosis in colorectal cancer.
    Jen J; Kim H; Piantadosi S; Liu ZF; Levitt RC; Sistonen P; Kinzler KW; Vogelstein B; Hamilton SR
    N Engl J Med; 1994 Jul; 331(4):213-21. PubMed ID: 8015568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma.
    Wang W; Wang GQ; Sun XW; Chen G; Li YF; Zhang LY; Qiu HB; Huang CY; Zhan YQ; Zhou ZW
    World J Gastroenterol; 2010 Dec; 16(47):6026-34. PubMed ID: 21157981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
    Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
    Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.
    Font A; Abad A; Monzó M; Sanchez JJ; Guillot M; Manzano JL; Piñol M; Ojanguren I; Rosell R
    Dis Colon Rectum; 2001 Apr; 44(4):549-57. PubMed ID: 11330582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel multiplexing, polymerase chain reaction-based assay for the analysis of chromosome 18q status in colorectal cancer.
    Erill N; Colomer A; Calvo M; Vidal A; Román R; Verdú M; Cordón-Cardó C; Puig X
    J Mol Diagn; 2005 Oct; 7(4):478-85. PubMed ID: 16237217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
    Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
    J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma.
    Lindforss U; Fredholm H; Papadogiannakis N; Gad A; Zetterquist H; Olivecrona H
    Cancer; 2000 Jun; 88(12):2661-7. PubMed ID: 10870047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
    Bertagnolli MM; Redston M; Compton CC; Niedzwiecki D; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS
    J Clin Oncol; 2011 Aug; 29(23):3153-62. PubMed ID: 21747089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of chromosome 1p allelic loss in colon cancer.
    Ogunbiyi OA; Goodfellow PJ; Gagliardi G; Swanson PE; Birnbaum EH; Fleshman JW; Kodner IJ; Moley JF
    Gastroenterology; 1997 Sep; 113(3):761-6. PubMed ID: 9287966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
    Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
    BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy number variations in DCC/18q and ERBB2/17q are associated with disease-free survival in microsatellite stable colon cancer.
    Sefrioui D; Vermeulin T; Blanchard F; Chapusot C; Beaussire L; Armengol-Debeir L; Sesboué R; Gangloff A; Hebbar M; Copin MC; Houivet E; Schwarz L; Clatot F; Tuech JJ; Bénichou J; Martin L; Bouvier AM; Sabourin JC; Sarafan-Vasseur N; Frébourg T; Lepage C; Michel P; Di Fiore F
    Int J Cancer; 2017 Apr; 140(7):1653-1661. PubMed ID: 28006840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer.
    de Manzoni G; Tomezzoli A; Di Leo A; Moore PS; Talamini G; Scarpa A
    Br J Surg; 2001 Mar; 88(3):419-25. PubMed ID: 11260110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
    Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
    J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
    Takebayashi S; Hickson A; Ogawa T; Jung KY; Mineta H; Ueda Y; Grénman R; Fisher SG; Carey TE
    Genes Chromosomes Cancer; 2004 Oct; 41(2):145-54. PubMed ID: 15287027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.